Filing Details
- Accession Number:
- 0001225208-15-016706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-11 14:00:16
- Reporting Period:
- 2015-08-07
- Filing Date:
- 2015-08-11
- Accepted Time:
- 2015-08-11 14:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1580664 | P John Groetelaars | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-07 | 5,194 | $84.58 | 22,841 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-07 | 4,222 | $86.15 | 27,063 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-07 | 9,416 | $196.68 | 17,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2015-08-07 | 4,222 | $0.00 | 4,222 | $86.15 |
| Common Stock | Option (Right to Buy) | Disposition | 2015-08-07 | 5,194 | $0.00 | 5,194 | $84.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-08 | No | 4 | M | Direct | |
| 2,597 | 2021-12-14 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for price increments ranging from $196.50 to $196.96. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options fully vested in accordance with schedule upon achievement of certain performance criteria.
- Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Of this option grant, 5,194 options are vested and the remaining 2,597 options vest on December 14, 2015.
Billionaire Hedge Funds
